Showing results (281-290 of 426) with videos related to
Sort By:
Pageof 43
American Heart Journal|December 12, 2018
Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trialNeha J Pagidipati, Adrian Coles, Kshipra Hemal, et al.Circulation|October 27, 2010
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic ResonanceAllen J Taylor, Manuel Cerqueira, John McB Hodgson, et al.The Journal of Biological Chemistry|January 30, 2020
The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimerKatharine Jennifer Goodall, Angela Nguyen, Craig McKenzie, et al.Journal of Cardiovascular Computed Tomography|January 15, 2011
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic ResonanceAllen J Taylor, Manuel Cerqueira, John McB Hodgson, et al.Toxics|June 25, 2025
The Metal Oxidation State in Cu, CuO, and Cu2O Nanoparticles Plays a Key Role in Toxicity to Sea Urchin Arbacia lixula, Paracentrotus lividus, and Sphaerechinus granularis EmbryosIvana Čarapar, Lara Jurković, Dijana Pavičić-Hamer, et al.European Heart Journal|December 4, 2003
International variation in the use of evidence-based medicines for acute coronary syndromesJudith M Kramer, L Kristin Newby, Wei Ching Chang, et al.Circulation. Arrhythmia and Electrophysiology|April 17, 2024
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA TrialT Jared Bunch, Jeanne E Poole, Adam P Silverstein, et al.American Heart Journal|February 9, 2002
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network TrialKenneth W Mahaffey, Matthew T Roe, Christopher K Dyke, et al.Journal of the American College of Cardiology|April 9, 2016
Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery DiseaseNeha J Pagidipati, Kshipra Hemal, Adrian Coles, et al.The American Journal of Cardiology|December 8, 2009
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery diseaseBrett D Atwater, Vivian P Thompson, Richard N Vest, et al.Pageof 43